The rapid inhibitory effect of insulin on the onset of oxidative stress observed in our study seems to explain, at least in part, the neuroprotective action of intranasal insulin in the treatment of Alzheimer’s disease [45] and experimental traumatic brain injury [46]. Here, INS is linked to early-onset autosomal dominant Alzheimer disease.